Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BARRECA, Marilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.121
NA - Nord America 1.081
AS - Asia 742
SA - Sud America 244
AF - Africa 32
OC - Oceania 1
Totale 3.221
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.056
IT - Italia 519
SG - Singapore 295
BR - Brasile 209
CN - Cina 184
RU - Federazione Russa 176
DE - Germania 150
HK - Hong Kong 99
PL - Polonia 74
VN - Vietnam 71
GB - Regno Unito 35
NL - Olanda 28
AT - Austria 21
FI - Finlandia 21
AR - Argentina 20
IE - Irlanda 19
IN - India 19
FR - Francia 18
CH - Svizzera 11
BD - Bangladesh 10
MX - Messico 10
BE - Belgio 9
CA - Canada 9
SE - Svezia 9
UA - Ucraina 9
JP - Giappone 8
MY - Malesia 7
TR - Turchia 7
ZA - Sudafrica 7
EG - Egitto 6
IQ - Iraq 6
KR - Corea 6
RO - Romania 6
KE - Kenya 5
UZ - Uzbekistan 5
EC - Ecuador 4
ID - Indonesia 4
PK - Pakistan 4
CO - Colombia 3
DZ - Algeria 3
IR - Iran 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
GH - Ghana 2
MA - Marocco 2
PA - Panama 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 3.221
Salva come PNG Salva come JPEG
Città #
Palermo 202
Ashburn 196
Singapore 173
Chandler 99
Hong Kong 78
Zgierz 71
Fairfield 62
The Dalles 47
Beijing 46
Moscow 45
Hefei 35
Chicago 32
Los Angeles 31
Milan 31
Woodbridge 27
Cambridge 26
Ann Arbor 24
Ludwigshafen am Rhein 24
Dallas 22
Hanoi 21
Santa Clara 21
Houston 20
Medford 20
Wilmington 20
Berlin 18
Central 18
Ho Chi Minh City 16
Nuremberg 16
São Paulo 16
Buffalo 15
Dublin 15
Rome 15
Helsinki 14
New York 14
Princeton 14
Altamura 13
Lawrence 13
Vienna 13
London 12
San Diego 12
Frankfurt am Main 10
Brussels 9
Council Bluffs 9
Naples 9
Lercara Friddi 8
Tampa 8
West Jordan 8
Belo Horizonte 7
Columbus 7
Lappeenranta 7
San Paolo di Civitate 7
Amsterdam 6
Andover 6
Boston 6
Des Moines 6
Lugano 6
Padova 6
Partanna 6
Rio de Janeiro 6
Seattle 6
Bengaluru 5
Cagliari 5
Cairo 5
Campinas 5
Capaci 5
Catanzaro 5
Corigliano Calabro 5
Curitiba 5
Hanover 5
Nairobi 5
Napoli 5
Orem 5
Redondo Beach 5
Buenos Aires 4
Civitanova Marche 4
Fortaleza 4
Haiphong 4
Kuala Lumpur 4
Porto Alegre 4
Rubano 4
Salt Lake City 4
Salvador 4
San Francisco 4
Shanghai 4
Stockholm 4
Tashkent 4
Tianjin 4
Timisoara 4
Tokyo 4
Americana 3
Ankara 3
Camaçari 3
Cape Town 3
Catania 3
Chennai 3
Da Nang 3
Eunpyeong-gu 3
Farnham 3
Genoa 3
Groningen 3
Totale 1.912
Salva come PNG Salva come JPEG
Nome #
Current development of CFTR potentiators in the last decade 228
[1,2]OXAZOLE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST MULTIPLE MALIGNANT CELL TYPES 187
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors 144
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 142
GPCR Inhibition in Treating Lymphoma 140
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 137
Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 133
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis 122
THE KEY ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTICANCER THERAPIES: A PILOT STUDY IN THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER 119
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes 118
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein 117
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells 116
Editorial: Emerging heterocycles as bioactive compounds 113
An overview on anti-tubulin agents for the treatment of lymphoma patients 107
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors 104
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel 101
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis 100
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 94
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis 92
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 85
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches 85
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas 85
New tricyclic systems as photosensitizers towards triple negative breast cancer cells 84
Secondary resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma 82
Advances in developing noncovalent small molecules targeting Keap1 81
Screening of fractions from marine sponges and other invertebrates to identify new lead compounds with anti-tumor activity in lymphoma models 80
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences 76
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas 75
Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity 71
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations 70
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 60
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors 51
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib 39
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma 37
Microwave‐Enhanced Synthesis of 2‐Styrylquinoline‐4‐Carboxamides With Promising Anti‐Lymphoma Activity 27
Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis 21
Totale 3.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.390
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 9 27 15 18 5 12 33
2021/2022291 29 37 7 6 5 14 16 9 63 33 15 57
2022/2023542 34 60 18 29 64 61 29 43 64 51 72 17
2023/2024346 15 32 14 46 22 29 75 36 10 12 19 36
2024/2025997 47 66 52 75 38 62 162 87 49 98 121 140
2025/20261.152 170 54 204 217 186 321 0 0 0 0 0 0
Totale 3.523